 HONG KONG, Aug. 9, 2021 PRNewswire -- Insilico Medicine is proud to announce an RD collaboration with Arvinas NASDAQ: ARVN. This strategic partnership will involve Insilico Medicines AI-augmented platforms and close cooperation between Arvinas and Insilico Medicines scientists on novel PROTACs. 